Metal nanoparticles in neuroinflammation: impact on microglial dynamics and CNS function

Masood Alaei1,2, Khadijeh Koushki3, Kimia Taebi1,2

  • 1Student Research Committee, Qazvin University of Medical Sciences Qazvin Iran.

RSC Advances
|February 19, 2025
PubMed

Insights

Metal nanoparticles (NPs) show a dual role in brain immune cell (microglia) activity. Some NPs reduce neuroinflammation, while others worsen it, impacting neurodegenerative disease treatments.

Area of Science:

  • Neuroscience
  • Nanotechnology
  • Immunology

Background:

  • Microglia are central nervous system immune cells vital for brain health.
  • Microglial activation contributes to neuroinflammation and neurodegenerative diseases.
  • Metal nanoparticles can cross the blood-brain barrier for CNS drug delivery.

Purpose of the Study:

  • To review the dual role of various metal nanoparticles (NPs) in modulating microglial activity.
  • To examine how different NPs influence microglial activation, considering therapeutic potential and risks.
  • To highlight the importance of understanding NP-microglia interactions for neurodegenerative disorder treatments.

Main Methods:

  • Literature review of studies on metal-containing NPs (AuNPs, AgNPs, IONPs, ZnONPs, CoNPs, TiO2NPs, SiO2NPs).
  • Analysis of NP effects on microglial activation pathways and inflammatory responses.
  • Evaluation of NP-mediated modulation of neuroinflammation in the context of CNS disorders.

Main Results:

  • Metal NPs exhibit a dichotomous effect on microglial activation: some are anti-inflammatory, others pro-inflammatory.
  • Specific NP types (e.g., AuNPs, IONPs) may offer therapeutic benefits by reducing neuroinflammation.
  • Other NPs (e.g., AgNPs, TiO2NPs) can exacerbate neuroinflammation, posing risks.

Conclusions:

  • Understanding the specific interactions between different metal NPs and microglia is critical.
  • Careful selection and design of NPs are necessary to harness therapeutic potential while mitigating risks.
  • Further research into NP-microglia dynamics will guide the development of novel treatments for neuroinflammatory and neurodegenerative diseases.